Anonymize prospectus supplement drafts for underwriter and legal review – CCPA/HIPAA-compliant de-identification per 15 USC §77j
Securities Act §77j governs prospectus delivery requirements and the information that must be included in prospectus supplements for shelf offerings under an effective registration statement. Prospectus supplements identify named selling shareholders, underwriters, and deal-specific counterparties. anonym.legal pseudonymizes those identifiers in supplement drafts so pricing-committee and legal teams can review terms before the pricing date.
When this applies
Apply this workflow when draft prospectus supplements for equity, debt, or convertible securities shelf offerings are circulated to the pricing committee, syndicate desk, or legal team before the offering pricing date where named selling-shareholder or counterparty identities are not required by the reviewer.
How anonym.legal handles it
- Upload the draft prospectus supplement in PDF or DOCX format to anonym.legal.
- The engine identifies named selling shareholders, lead underwriters, co-managers, and named counterparties in the supplement.
- Each named individual and entity is pseudonymized consistently across the front cover, selling-shareholder table, underwriting section, and plan of distribution.
- Pricing terms, offering size, underwriting discount, use of proceeds, and maturity date (for debt offerings) are retained as structural content.
- The base prospectus incorporated by reference is processed separately if required for consistent pseudonymization.
- The reversible mapping is stored encrypted for re-identification at pricing.
- The pseudonymized supplement draft is exported for committee and legal review.
What you provide
- Draft prospectus supplement in PDF or DOCX format
- Preliminary pricing term sheet if circulated separately
- Scope instruction identifying which named parties require pseudonymization
Limitations & cautions
- anonym.legal does not assess whether the prospectus supplement satisfies Securities Act §77j delivery requirements or SEC rule shelf-eligibility conditions; those determinations require securities counsel.
- Prospectus supplements for complex structured products may contain counterparty-referencing terms that require individual legal review beyond automated pseudonymization.
- The tool does not file or transmit the prospectus supplement to the SEC or any clearance system.
- Re-identification is required before the final supplement is filed and printed for distribution to investors.
FAQ
Can this workflow handle both equity and debt prospectus supplements?
Yes. The workflow applies to equity shelf supplements, debt shelf supplements, and convertible-note supplements alike. The pseudonymization logic covers named parties in both the front matter and the plan-of-distribution section regardless of security type.
Will the underwriting syndicate table be pseudonymized?
Yes. Named lead underwriters, co-managers, and their share allocations in the syndicate table are pseudonymized at the entity level while the underwriting discount and stabilization terms are preserved as structural content.
Is this workflow relevant for ATM (at-the-market) offering program supplements?
Yes. ATM equity distribution agreement supplements naming the sales agent are processed with consistent pseudonymization. The offering mechanics, pricing methodology, and distribution-plan description are preserved in plain text.